CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The 2D-BioPAD project develops a non-invasive tool for early diagnosis of Alzheimer's Disease, focusing on initial stages like Subjective or Mild Cognitive Impairment. This point-of-care solution aims to improve prognosis accuracy and accessibility for patients.
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).
UNIVERZITA PALACKEHO V OLOMOUCI
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Greece, Kalamaria, Thessaloniki
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Spain, Cerdanyola Del Valles
Type: Research institute
Activity type: Research Organisations
SME: No
France, Grenoble
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece, THESSALONIKI
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
